# Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)

> **NCT03282929** · PHASE1 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 43 (actual)

## Conditions studied

- Anaphylaxis

## Interventions

- **DEVICE:** Part 1
- **DEVICE:** Part 2 Group 1
- **DRUG:** Part 2 group 2
- **DEVICE:** Part 2 group 3
- **DEVICE:** Part 2 Group 4

## Key facts

- **NCT ID:** NCT03282929
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-23
- **Primary completion:** 2018-09-28
- **Final completion:** 2018-10-15
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03282929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03282929, "Study to Explore the Pharmacokinetics and Pharmacodynamics of Epinephrine in Healthy Male and Female Subjects With Different Skin to Muscle Depth (STMD)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03282929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*